Market Quotes

2212 items in section

Veradermics Shares More Than Double in Explosive NYSE Debut

Veradermics, a New Haven-based biotech firm developing hair loss treatments, saw its shares surge over 100% in its New York Stock Exchange debut on Tuesday. The company’s upsized initial public offering priced at $17 per share, raising significant capital as it advances a potential first-of-its-kind non-hormonal oral therapeutic for hair regrowth.

MGM Resorts Shares Jump as Preliminary Q4 Earnings Beat Estimates

MGM Resorts International shares surged Wednesday after the company reported preliminary fourth-quarter results that comfortably exceeded Wall Street expectations. Driven by a sharp rise in casino revenue, the hotel and gaming operator expects to post a profit of $293.6 million, nearly doubling its performance from the same period last year.

Powell Industries Stock Hits 52-Week High as Order Backlog Swells

Powell Industries shares jumped 19% to a 52-week high on Wednesday after the electrical equipment supplier reported a surge in new orders and first-quarter earnings that beat analyst estimates. The Houston-based company reached $540.00 in midday trading, marking a performance that has seen its valuation more than double over the past year.

Hershey Braces for Profit Slump as Cocoa Costs Squeeze Margins

Hershey is set to report its fourth-quarter results on Thursday morning, with Wall Street bracing for a significant drop in earnings despite a modest rise in revenue. As the confectioner grapples with historic spikes in cocoa prices, analysts polled by FactSet expect net income to plummet to $320.6 million, down from $796.6 million during the same period last year.

U.S. Natural Gas Storage Set for Record 374 Bcf Withdrawal

U.S. natural gas inventories are poised for a historic contraction following Winter Storm Fern, with analysts forecasting a record-breaking 374 billion cubic feet (Bcf) withdrawal for the week ended Jan. 30. This massive drain, fueled by a surge in heating demand and crippled production, is expected to flip the national supply from a comfortable surplus to a deficit against the five-year average.

Cigna Forecast to Post Strong Q4 Profit Amid Regulatory Headwinds

Cigna Group is expected to report a significant jump in fourth-quarter profit and revenue on Thursday morning, driven by robust performance across its healthcare segments. While analysts polled by FactSet anticipate a net income of $1.74 billion, the health insurance giant faces mounting scrutiny over its pharmacy-benefit margins and a shifting regulatory landscape for Medicare Advantage.

WTI Crude Slips as EIA Data Offsets U.S. Production Freeze-Offs

U.S. crude oil futures reversed early gains on Wednesday, turning lower after Energy Information Administration data revealed rising gasoline stocks and a weather-induced slump in demand. While a severe cold snap triggered a significant drop in domestic production, the supply contraction failed to offset bearish signals from the refined products market.

Suncor Shares Surge as Record Production Drives Earnings Beat

Suncor Energy shares advanced on Wednesday after the Canadian oilsands giant reported fourth-quarter earnings that surpassed analyst estimates, fueled by record upstream production and refining volumes. The Calgary-based producer achieved its multi-year financial targets a full year ahead of schedule, signaling a successful operational turnaround under its current leadership.

TSX Retreats as Service Sector Slump Weighs on Corporate Gains

Toronto stocks edged lower on Wednesday as a sharp contraction in Canada’s services sector dampened investor sentiment, overshadowing a series of upbeat earnings reports and strategic leadership shifts. The S&P/TSX Composite Index fell 0.4% to 32270.76, while the blue-chip S&P/TSX 60 slipped 0.2% to 1870.45.

Bristol Myers Squibb Q4 Preview: Revenue Dips Amid Patent Pressures

Bristol Myers Squibb is scheduled to release its fourth-quarter results Thursday morning, with analysts anticipating a slight revenue decline as the pharmaceutical giant navigates the expiration of key drug patents. While net income is expected to rise significantly from the previous year, the focus remains on whether the company's new product launches can effectively bridge the gap left by its aging blockbusters.

Kingstone Shares Surge on Bullish 2025 Earnings Forecast

Kingstone Companies shares climbed 14% to $17.34 after the insurance holding company issued fourth-quarter and fiscal 2025 guidance that significantly outpaces prior-year results. The optimistic outlook reflects a sharp turn toward profitability driven by premium growth and refined risk selection.

FTC Settles With Express Scripts to Lower Insulin Prices

The Federal Trade Commission has finalized a settlement with Express Scripts, resolving a lawsuit that accused the pharmacy benefit manager of driving up insulin costs through anticompetitive rebating schemes. The agreement mandates a shift toward lower-cost drug options and increased transparency, marking a significant move to reduce out-of-pocket healthcare expenses for millions of Americans.

EU Parliament Resumes Progress on 'Turnberry' Trade Deal With U.S.

European lawmakers have agreed to restart the ratification process for the 'Turnberry Deal,' a major trade agreement with the United States that stalled earlier this year following diplomatic tensions over Greenland. The move signals a de-escalation after the White House rescinded threats to impose tariffs on European nations.

Lamb Weston Overhauls Leadership Amid Activist Investor Pressure

Lamb Weston Holdings has appointed former Anheuser-Busch InBev executive Jan Craps as its first executive chair and named James Gray as its new chief financial officer. The management shakeup, announced Wednesday, signals a strategic pivot for the Boise-based potato giant as it seeks to accelerate growth and address demands from activist investors.

Kennametal Stock Hits 52-Week High on Strong Q2 Results and Guidance

Kennametal shares surged 13% on Tuesday after the industrial tools manufacturer reported second-quarter sales and earnings that comfortably cleared Wall Street estimates. The rally, which pushed the stock to a new 52-week high, follows a period of robust growth as the company navigates shifting commodity prices and improving industrial demand.

ATS Shares Surge as Automation Demand Drives Revenue Beat

ATS Corp. shares climbed Wednesday after the Canadian automation specialist reported third-quarter revenue that exceeded both internal guidance and analyst forecasts. Driven by organic growth across most segments and a rebound in order bookings, the company signaled resilience despite recent leadership transitions.

U.S. Crude Stocks Drop as Winter Storm Fern Disrupts Production

U.S. crude oil inventories fell by 3.5 million barrels last week as production freeze-offs caused by Winter Storm Fern outweighed a surge in imports. According to data released Wednesday by the Energy Information Administration, commercial stockpiles dropped to 420.3 million barrels for the week ended Jan. 30, defying analyst expectations of a neutral reading.

Reynolds Consumer Products Stock Surges Despite Soft Outlook

Reynolds Consumer Products shares rallied on Wednesday after the household staples manufacturer posted fourth-quarter revenue that topped Wall Street estimates. While the maker of Reynolds Wrap met earnings expectations, its stock jumped 12% to $24.46 in morning trading, recovering some ground after a year-long slump.

Boston Scientific Shares Sink on Weak First-Quarter Guidance

Boston Scientific shares plummeted on Wednesday after the medical device maker issued a first-quarter outlook that fell short of Wall Street estimates, overshadowing a strong finish to the previous fiscal year. Despite beating fourth-quarter earnings expectations, the company’s conservative short-term projections triggered the stock's sharpest intraday decline in over two decades.

Azenta Shares Crater Following Q1 Earnings Miss and Widening Loss

Azenta stock plummeted Wednesday morning after the life sciences company reported a fiscal first-quarter loss that exceeded analyst projections. Despite a slight uptick in total revenue, the firm’s adjusted earnings fell short of Wall Street estimates, intensifying pressure on its valuation.

Adient Shares Surge as 2026 Outlook Beats Wall Street Estimates

Shares of Adient jumped 13% on Wednesday after the automotive-seating manufacturer raised its long-term financial guidance, citing a more robust outlook for global vehicle production. The company now expects to outperform previous revenue and earnings projections for 2026, signaling confidence in its operational resilience despite a quarterly net loss.

Cencora Shares Slump as Revenue Misses Wall Street Targets

Cencora shares tumbled Wednesday morning after the pharmaceutical distribution giant reported fiscal first-quarter revenue that fell short of analyst expectations, overshadowing a beat on adjusted earnings and an upgraded long-term growth outlook.

BNP Paribas Earnings: Capital Targets and Revenue Growth in Focus

BNP Paribas is set to report its fourth-quarter 2025 results this Thursday, with analysts forecasting a jump in revenue to 12.86 billion euros ($15.20 billion) driven by retail strength and the integration of AXA IM. As the Paris-based lender navigates a shifting regulatory landscape, investors are laser-focused on whether the bank will accelerate its capital ratio targets or prioritize shareholder returns through dividends.